Claritev Corp. (CTEV)
NYSEHealth CareHealth Information ServicesSnapshot 2026-07-07
$31.79-4.13%
Close 2026-07-07 · 1-day change
Reading CTEV? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CTEV free→NYSEHealth CareHealth Information ServicesSnapshot 2026-07-07
Reading CTEV? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CTEV free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a turnaround story with a focus on improving operating income and cash flow. The current thesis state is intact, supported by recent strong financial performance, but the company remains loss-making.
The market appears to have priced in a justified valuation, with CTEV being considered cheap compared to its peers. The expectations gap suggests that the market anticipates challenges, particularly given the company's recent earnings misses.
Management is on track to improve operating income, but cash flow remains volatile, indicating mixed progress. Revenue has stabilized around $240 million, but growth is limited, which could impact future performance.
The long-term thesis hinges on the performance of sector bellwethers like VEEV, BTSG, and TEM. If these companies continue to perform well, it could provide a favorable backdrop for CTEV, while any negative guidance from them could pose risks.
Over the next 1 to 3 years, CTEV's performance will depend on its ability to stabilize cash flow and navigate sector dynamics. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-07
No named catalysts to watch right now. Check back after the next earnings report.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.